Global Point-of-Care Diagnostics / Testing (POCT) Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • ID: 4313389
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer AG
  • Danaher Corporation
  • Johnson & Johnson
  • MORE

The point-of-care diagnostics / testing market was valued at USD 15,743.6 Mn in 2015, and is expected to reach USD 27,507.2 Mn by 2022, expanding at a CAGR of 8.1% from 2016 to 2022.

Market Insights
Point-of-care tests (POCT) are the type of diagnostic tests performed outside the central laboratory or decentralized testing. The technological evolution in the field of diagnostics including introduction of portable and handheld instruments has resulted in the shift of POC testing from the hospitals to several medical environments including the workplace, home, disaster care and convenience clinics. POC diagnostics offers high potential for diagnosis and treatment of patients, as it assists rapid availability of test results and hence, earlier clinical decision making and intervention. The factors aiding the growth of POC testing market are mounting disease incidence, rising public awareness related to diagnosis of infectious diseases, growing focus towards personalization of care and constant integration of technology into healthcare. POC testing is becoming one of the integral parts of diagnosis and monitoring patient care market. Novel technologies are enabling POC devices to generate quantitative lab-quality test results that can be transferred to a central information system, remote caregiver service for consultation or electronic medical record database.

Market Competition Assessment:
The point-of-care diagnostics or testing market is observed as the most diversified and competitive market comprising large number of players. The market observed one of the highest rates of merger and acquisition activity leading to investments in novel technologies as companies with strong capital back-up enter the sector. The market is dominated by several players, depending on their major competencies. The key players in this market are Roche Diagnostics Ltd., Abbott Laboratories, Alere Inc., Siemens AG, and Beckman Coulter, Inc.

Key Market Movements:

  • High prevalence of infectious diseases and rising incidences of lifestyle diseases in developing countries
  • Rising usage of home-based POC testing devices is improving patient complianc
  • Increasing private investments and venture funding along with growing government support in development of new products and adoption of current POC devices is assisting the market growth
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer AG
  • Danaher Corporation
  • Johnson & Johnson
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 Usp and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Point-Of-Care Diagnostics/Testing Market, by Product Type, 2015 (USD Mn)
2.2 Point-Of-Care Diagnostics/Testing Market Share, by End Users, 2015 & 2022 (Value %)
2.3 Point-Of-Care Diagnostics/Testing Market Share, by Geography, 2015 (Value %)

Chapter 3 Global Point-Of-Care Diagnostics/Testing Market: Market Dynamics and Outlook
3.1 Point-Of-Care Diagnostics/Testing: Current and Future Trends
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key Point-Of-Care Diagnostics/Testing Manufacturers, 2015 (%)

Chapter 4 Global Point-Of-Care Diagnostics/Testing Market Analysis, by Product Type
4.1 Preface
4.2 Glucose Monitoring
4.3 Cardiac Markers
4.4 Infectious Diseases Testing
4.5 Cholesterol Testing
4.6 Coagulation Monitoring
4.7 Pregnancy and Fertility Testing
4.8 Hematology Testing
4.9 Blood Gas Testing
4.10 Others

Chapter 5 Global Point-Of-Care Diagnostics/Testing Market Analysis, by End-User
5.1 Preface
5.2 Clinics
5.3 Home
5.4 Laboratories
5.5 Assisted Living Healthcare Facilities
5.6 Hospitals

Chapter 6 Global Point-Of-Care Diagnostics/Testing Market, by Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific
6.5 Latin America (Latam)
6.5.1 Brazil
6.5.2 Mexico
6.5.3 Rest of Latam
6.6 Middle East and Africa (Mea)

Chapter 7 Future Growth Advocacies

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 Key Competitors
8.1.5 News Coverage
8.2 Abaxis, Inc
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 Key Competitors
8.2.5 News Coverage
8.3 Alere, Inc
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 Key Competitors
8.3.5 News Coverage
8.4 Bayer Ag
8.4.1 Business Description
8.4.2 Financial Health and Budget Allocation
8.4.3 Product Positions/
8.4.4 Key Competitors
8.4.5 News Coverage
8.5 Danaher Corporation
8.5.1 Business Description
8.5.2 Financial Health and Budget Allocation
8.5.3 Product Positions/Portfolio
8.5.4 Key Competitors
8.5.5 News Coverage
8.6 Becton, Dickinson and Company
8.6.1 Business Description
8.6.2 Financial Health and Budget Allocation
8.6.3 Product Positions/Portfolio
8.6.4 Key Competitors
8.6.5 News Coverage
8.7 Johnson & Johnson
8.7.1 Business Description
8.7.2 Financial Health and Budget Allocation
8.7.3 Product Positions/Portfolio
8.7.4 Key Competitors
8.7.5 News Coverage
8.8 Nipro Corporation
8.8.1 Business Description
8.8.2 Financial Health and Budget Allocation
8.8.3 Product Positions/Portfolio
8.8.4 Key Competitors
8.8.5 News Coverage
8.9 Roche Diagnostics Limited
8.9.1 Business Description
8.9.2 Financial Health and Budget Allocation
8.9.3 Product Positions/Portfolio
8.9.4 Key Competitors
8.9.5 News Coverage
8.10 Siemens Healthcare
8.10.1 Business Description
8.10.2 Financial Health and Budget Allocation
8.10.3 Product Positions/Portfolio
8.10.4 Key Competitors
8.4.5 News Coverage
8.11 Samsung Medison Co. Ltd
8.11.1 Business Description
8.11.2 Financial Health and Budget Allocation
8.11.3 Product Positions/Portfolio
8.11.4 Key Competitors
8.11.5 News Coverage

List of Figures
Figure 1 Point-Of-Care Diagnostics / Testing: Market Segmentation
Figure 2 Point-Of-Care Diagnostics / Testing Market, by Product Type, 2015 (USD Mn)
Figure 3 Point-Of-Care Diagnostics / Testing Market Share, by End-Users, 2015 & 2022 (Value %)
Figure 4 Point-Of-Care Diagnostics / Testing Market Share, by Geography, 2015 (Value %)
Figure 5 Attractive Investment Proposition, Point-Of-Care Diagnostics / Testing Market, 2015
Figure 6 Key Players Market Share Analysis for Point-Of-Care Diagnostics / Testing, 2015(%)
Figure 7 Global Glucose Monitoring Products Market Revenue, 2013 - 2022 (USD Mn)
Figure 8 Global Cardiac Markerproducts Market Revenue, 2013 - 2022 (USD Mn)
Figure 9 Global Infectious Diseases Testing Products Market Revenue, 2013 - 2022 (USD
Mn)
Figure 10 Global Cholesterol Testing Products Market Revenue, 2013 - 2022 (USD Mn)
Figure 11 Global Coagulation Monitoring Products Market Revenue, 2013 - 2022 (USD Mn)
Figure 12 Global Pregnancy and Fertility Testing Products Market Revenue, 2013 - 2022 (USD Mn)
Figure 13 Global Hematology Testing Products Market Revenue, 2013 - 2022 (USD Mn)
Figure 14 Global Blood Gas Testing Products Market Revenue, 2013 - 2022 (USD Mn)
Figure 15 Global Other Products Market Revenue, 2013 - 2022 (USD Mn)
Figure 16 Global Clinics in Point-Of-Care Diagnostics/Testing Market Revenue, 2013 - 2022
(USD Mn)
Figure 17 Global Home in Point-Of-Care Diagnostics/Testing Market Revenue, 2013 - 2022 (USD
Mn)
Figure 18 Global Laboratories in Point-Of-Care Diagnostics/Testing Market Revenue, 2013 - 2022
(USD Mn)
Figure 19 Global Assisted Living Healthcare Facilities in Point-Of-Care Diagnostics/Testing Market
Revenue, 2013 - 2022 (USD Mn)
Figure 20 Global Hospitals in Point-Of-Care Diagnostics/Testing Market Revenue, 2013 - 2022 (USD
Mn)

List of Tables
Table 1 Global Point-Of-Care Diagnostics/Testing Market Revenue, by Product Type, 2013 - 2022 (USD Mn)
Table 2 Global Point-Of-Care Diagnostics/Testing Market Revenue, by Technology, 2013 - 2022 (USD Mn)
Table 3 Global Point-Of-Care Diagnostics/Testing Market Revenue, by Geography, 2013 - 2022 (USD Mn)
Table 4 North America Point-Of-Care Diagnostics/Testing Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 5 Europe Point-Of-Care Diagnostics/Testing Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 6 Asia - Pacific Point-Of-Care Diagnostics/Testing Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 7 Latin America Point-Of-Care Diagnostics/Testing Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 8 Middle East and Africa Point-Of-Care Diagnostics/Testing Market Revenue, by Region, 2013 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories, Inc.
  • Abaxis, Inc.
  • Alere, Inc.
  • Bayer AG
  • Danaher Corporation
  • Becton, Dickinson And Company
  • Johnson & Johnson
  • Nipro Corporation
  • Roche Diagnostics Limited
  • Siemens Healthcare
  • Samsung Medison Co. Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll